Esketamine 84 mg Clinical Trials

1 actively recruiting trial

Also known as: JNJ-54135419

Pipeline

Phase 4: 1

Top Sponsors

Janssen Korea, Ltd., Korea1

Indications

Depressive Disorder, Treatment-Resistant1
Depression1

Other1 trial

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.